LTR Pharma (ASX:LTP) said its SPONTAN nasal spray product will be available through TerryWhite Chemmart's pharmacy network in Australia under its earlier distribution agreement with Symbion, according to a Tuesday Australian bourse filing.
TerryWhite Chemmart is a subsidiary of EBOS Group (ASX:EBO, NZE:EBO) alongside Symbion, the filing said.
LTR Pharma developed new commercial packaging for the SPONTAN intranasal spray, designed for pharmacy distribution and incorporating Therapeutic Goods Administration-compliant labeling, patient information materials, and pharmacy-standard barcodes.
The expanded pharmacy rollout will allow the firm to gather real-world data on SPONTAN usage to support its regulatory strategy and preparations for a full commercial launch following regulatory approval in Australia.
Its shares jumped over 38% in recent trading on Tuesday.